Bipolar Coagulator Market: Current Analysis and Forecast (2022-2028)

Bipolar coagulation forceps act as hemostatic devices that control bleeding during surgical procedures. The growing demand for minimally invasive surgeries and the rising usage of technologically advanced products are propelling the market growth. According to the World Health Organization (WHO), in 2019, it was reported that around 235 million major surgeries are conducted every year across the globe. Moreover, the rising awareness about the most recent surgical methods in developing regions is expected to drive the bipolar coagulator market.

The Bipolar coagulator Market is expected to grow at a steady rate of around 6% owing to the increasing demand for the use of minimally invasive surgeries and increased incidences of tumors. Major companies are adopting several growth strategies, such as product launches, acquisitions, and collaborations, contributing to the global bipolar coagulator market. For instance, in May 2022, B. Braun and Massachusetts General Hospital Collaborated on healthcare delivery challenges. This collaboration is focused on bringing to life nursing ideas and business models to deliver care more efficiently and productively while also enhancing the work life and well-being of care teams.

Based on product type, the market is segmented into generators, instruments, and accessories. Instruments are sub-segmented into advanced vessel sealing instruments, and bipolar forceps. Accessories are sub-segmented into electrodes, cords, cables, adapters, foot switches, and carts. Among these, bipolar forceps held a significant share in 2020. Bipolar forceps securely grasp tissue, precisely dissect it, and alleviate the demand for surgical clips or staples. In various surgical techniques, bipolar forceps can be used to seal a vessel in two locations that raised the demand for bipolar forceps in microsurgical procedures.

On the basis of application, the market is categorized into laparoscopic surgery, orthopedics, neurosurgery, gynecology surgery, and others. Among these, the neurosurgery segment is expected to grow at a significant CAGR during the forecast period. Bipolar coagulation is widely used during operations to control blood loss and to seal tissue. This can be used safely and without difficulty in neurosurgical procedures that drive the segment.

Based on end users, the bipolar coagulator market has been classified into hospitals, trauma centers, ambulatory surgical centers, and others. The hospitals held a significant market share in 2020. This is mainly due to the high number of patients admitted to hospitals for a variety of conditions, increasing patient awareness, and the availability of advanced medical devices.

For a better understanding of the market adoption of the Bipolar coagulator industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. Asia Pacific is expected to grow at a substantial CAGR during the forecast period. This is mainly due to the rapidly rising number of surgeries being performed globally, and the increasing prevalence of various chronic diseases that are fueling the growth of the bipolar coagulator market. A significant reason driving demand for bipolar coagulator techniques and devices is the expanding geriatric population around the world, which is more susceptible to diseases like cardiac arrest, cancer, and intestinal and gastrointestinal diseases due to a weakened immune system. As per the Globocan 2020, approx. 4.6 billion people are affected by cancer in Asia. Therefore, the improved healthcare systems and increased research efforts drive market growth in the Asia Pacific region.

Some of the major players operating in the market include: B. Braun SE, Symmetry Surgical Inc., Apyx Medical, Medtronic, XCELLANCE MEDICAL TECHNOLOGIES PVT LTD, Olympus Corporation, Karl Storz, CONMED Corporation, Boston Scientific Corporation, Smith & Nephew.